文献速递血栓与止血

远端深静脉血栓后血栓后综合征的长期风险:CACTUS-PTS研究

Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study.
PubMed 文献 · J Thromb Haemost · 2020-02-11

CACTUS-PTS研究对CACTUS双盲试验患者进行长期随访,中位6年时30%的可评估患者(54/178)发生血栓后综合征(PTS),其中24%为中重度。

要点

  • 首次孤立性远端DVT后长期PTS风险达30%,但远低于近端DVT。

核心结论

  • 首次孤立性远端DVT后PTS风险可观但远低于近端DVT。
  • 那屈肝素抗凝对预防PTS无明确总体获益,仅在无原发性慢性静脉功能不全患者中可能有益。
  • 抗凝可能与较低的静脉血栓栓塞复发风险相关。

研究设计与样本

  • CACTUS双盲试验的长期随访研究,比较6周皮下那屈肝素(171 IU/kg/d)与安慰剂治疗首次症状性孤立性远端DVT。
  • 随机化后至少1年进行PTS评估,采用Villalta量表(VS)在门诊或电话完成。

主要发现

  • 中位随访6年,178例完成PTS评估的患者中30%(n=54)存在PTS。
  • PTS为中重度者占24%(n=13)。

临床怎么用

  • 对首次孤立性远端DVT患者应长期关注PTS发生风险。
  • 那屈肝素抗凝不宜仅以预防PTS为目的常规延长使用,需结合慢性静脉功能不全状态个体化评估。

局限性

  • PTS评估仅在完成评估的178例患者中进行,可能存在选择偏倚。
  • 原文未报告评估率、失访情况及多因素校正结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After a proximal lower limb deep vein thrombosis (DVT; involving popliteal veins or above), up to 40% of patients develop postthrombotic syndrome (PTS) as assessed by the Villalta scale (VS). Poor initial anticoagulant treatment is a known risk factor for PTS. The risk of developing PTS after isolated distal DVT (infra-popliteal DVT without pulmonary embolism), and the impact of anticoagulant treatment on this risk, are uncertain. METHODS: Long-term follow-up of CACTUS double-blind trial comparing 6 weeks of s.c. nadroparin (171 IU/kg/d) versus s.c. placebo for a first symptomatic isolated distal DVT. At least 1 year after randomization, patients had a PTS assessment in clinic or by phone using the VS. RESULTS: After a median follow-up of 6 years, PTS was present in 30% (n = 54) of the 178 patients who had a PTS assessment. PTS was moderate or severe in 24% (n = 13) of cases. There was no statistically significant difference in prevalence of PTS in the nadroparin versus placebo groups (29% versus 32%, P = .6), except in patients without evidence of primary chronic venous insufficiency (9% versus 24%, P = .04). Rates of venous thromboembolism recurrence during follow-up in the nadroparin and placebo groups were, respectively, 8% (n = 7) and 14% (n = 13; P = .2). CONCLUSION: After a first isolated distal DVT, the risk of PTS is substantial but much lower than that reported after proximal DVT. Anticoagulation with nadroparin doesn't provide any clear benefit to prevent PTS, except in patients without preexisting chronic venous insufficiency. Anticoagulation might be associated with a lower risk of venous thromboembolism recurrence.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020. PMID: 31899848. doi:10.1111/jth.14728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。